ID   CP50-EBV
AC   CVCL_UY79
SY   CP50EBV
DR   Cell_Model_Passport; SIDM01716
DR   DepMap; ACH-002346
DR   Wikidata; Q93457391
RX   PubMed=20164919;
RX   PubMed=20364150;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1143 ! CP50-MEL-B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 9
//
RX   PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113;
RA   Bignell G.R., Greenman C.D., Davies H.R., Butler A.P., Edkins S.,
RA   Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S.,
RA   Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T.,
RA   Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.;
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=20364150; DOI=10.1038/ni.1862;
RA   Parmentier N., Stroobant V., Colau D., de Diesbach P., Morel S.,
RA   Chapiro J., van Endert P.M., van den Eynde B.J.;
RT   "Production of an antigenic peptide by insulin-degrading enzyme.";
RL   Nat. Immunol. 11:449-454(2010).
//